A new study found that infants receiving maternal Respiratory Syncytial Virus (RSV) vaccination or Nirsevimab after birth had significantly lower RSV infection and health care use compared to ...
(Saturday, 18 April 2026, Munich, Germany) The largest real-world study of its kind, presented today at ESCMID Global 2026, shows that maternal vaccination against respiratory syncytial virus (RSV) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results